Recollections on the discovery of factor VIIa as a novel therapeutic agent for hemophiliacs with inhibitors
Calcium signaling in platelets
Antiphospholipid and anti-PF4 antibodies: an association affecting anti-PF4/heparin assay analysis
False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus
Lupus anticoagulants and anti-phospholipid antibodies as risk factors for a first episode of ischemic stroke
Allele-specific alternative splicing; the tail of FXIII-B tells its own tale
Distinct C-terminus of the B subunit of factor XIII in a population-associated major phenotype: the first case of complete allele-specific alternative splicing products in the coagulation and fibrinolytic systems
Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice
Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice
Type 2A (IIH) von Willebrand disease is due to mutations that affect von Willebrand factor multimerization
Optimizing warfarin reversal – an ex vivo study
Dexamethasone induces a heat-stress response that ameliorates the conformational consequences on antithrombin of l-asparaginase treatment
Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factor
Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra-low-molecular-weight heparin, AVE5026
Blocking von Willebrand factor: a novel anti-platelet therapy
Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779
Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17)
Doxorubicin-induced platelet cytotoxicity: a new contributory factor for doxorubicin-mediated thrombocytopenia
New insights into the expression and role of platelet factor XIII-A
The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets
Integrin α2β1 induces phosphorylation-dependent and phosphorylation-independent activation of phospholipase Cγ2 in platelets: role of Src kinase and Rac GTPase
Overexpression of the partially activated αIIbβ3D723H integrin salt bridge mutant downregulates RhoA activity and induces microtubule-dependent proplatelet–like extensions in Chinese hamster ovary cells
Biosimilar low molecular weight heparin products
Recommendations on biosimilar low-molecular-weight heparins
Rapid and accurate method for the von Willebrand factor ristocetin cofactor assay using 96-well microtiter plates
Simultaneous control of hyperglycemia and oxidative stress normalizes enhanced thrombin generation in type 1 diabetes
Inhibitor complexes of the plasma kallikrein–kinin system and outcome prediction in patients following admission for chest pain
Characterization of a novel mutation in the F8 promoter region associated with mild hemophilia A and resistance to DDAVP therapy
Long-term outcome after percutaneous coronary intervention in patients with essential thrombocythemia
No linkage for venous thrombosis at a candidate region on chromosome 18 in Dutch thrombophilic families
IL-10 inhibits apoptosis and microvesiculation of human monocytes